Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Journal for Immunotherapy of Cancer|April 25, 2024
Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccinationRobert A Watson, Weiyu Ye, Chelsea A Taylor, et al.
Cancer Cell|April 30, 2013
Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPPMin Lu, Hilde Breyssens, Victoria Salter, et al.
The Lancet. Oncology|April 22, 2014
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 studyPippa G Corrie, Andrea Marshall, Janet A Dunn, et al.
Cell Reports. Medicine|February 28, 2024
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trialJames Larkin, Richard Marais, Nuria Porta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2014
Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutationsLisa Zimmer, Fabrice Barlesi, Maria Martinez-Garcia, et al.
Trials|August 7, 2019
Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis PlanSerigne N Lo, Angela M Hong, Lauren E Haydu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2025
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 PatientsTakami Sato, Marcus O Butler, Sophie Piperno-Neumann, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2019
Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelinesKetty Peris, Maria Concetta Fargnoli, Claus Garbe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2025
Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic MelanomaReinhard Dummer, Shahneen Sandhu, Wilson H Miller, et al.
The Lancet. Oncology|June 23, 2023
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort studyBrian D Nicholson, Jason Oke, Pradeep S Virdee, et al.
Pageof 14